RSS feed for this section

CDF Joins With Teal Pumpkin Project to Raise Awareness of Celiac Disease and Food Allergies


Celiac Disease Foundation is pleased to announce its pledge of support for the Teal Pumpkin Project™, an international initiative that promotes safety, inclusion, and respect of individuals managing food allergies by encouraging households to display a teal pumpkin and provide non-food treats for trick-or-treaters. The Teal Pumpkin Project™ launched as an international campaign last year […]

CDF Endorses “Gluten in Medicine Identification Act”


In 2013, Representative Tim Ryan (D-Ohio) introduced legislation that would apply gluten labeling requirements on all medications, both prescription and over-the-counter. We strongly endorsed this legislation when it was first introduced in 2013, but it never made it to a vote. This year, we pledge to re-double our efforts, along with other celiac disease organizations, […]

CDF Urges You to Support the 21st Century Cures Act


In a rare moment of bipartisan cooperation in Washington, D.C., the landmark 21st Century Cures legislation passed the U.S. House in early July, 2015, by a vote of 344-77. The bill seeks to bring new drugs and treatments to market faster by encouraging medical innovation in research, and streamlining some FDA requirements.

CDF Attends Precision Medicine Working Group Meeting in Washington D.C.


CDF is committed to advancing the delivery of personalized health solutions emerging from the rapidly developing fields of genomics and data collection and analysis. We are a lead institutional participant in the Community Engaged Network for All (CENA), a ground-breaking initiative to create a massive national patient-driven cohort for disease research. The White House has launched […]

CDF Presents Patient-Focused Celiac Drug Development Survey Data to FDA


On May 11, 2015, the Food and Drug Administration (FDA) will conduct a public meeting on Functional GI Disorders Patient-Focused Drug Development. Celiac Disease Foundation was requested by the FDA to provide commentary about the impact of celiac disease on patients’ daily lives, the types of treatment benefit that matter most to patients, and patients’ […]

CDF Funds FDA GREAT3 Workshop in Washington, D.C.


On March 30-31st, 2015, Celiac Disease Foundation Chief Executive Officer, Marilyn G. Geller, attended the FDA Public Workshop on Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT3) near Washington, D.C. This landmark conference addressed endpoints and outcome measures for trials for products intended to treat celiac disease and Irritable Bowel Disease. The second day […]